- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有74家主力机构披露2025-06-30报告期持股数据，持仓量总计2.70亿股，占流通A股49.71%
- 波段诊断：
-
技术面诊股
诊断结果：8.4技术面打败了89%的股票
技术面评分前10的股票
近期的平均成本为7.92元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为7.92元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"7.92","date":1761121304,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，跑赢行业平均水平。
[{"date":"2025.10.23","stock":"-2.69","trade":null,"ind":"0.22"},{"date":"2025.10.22","stock":"6.36","trade":null,"ind":"-0.62"},{"date":"2025.10.21","stock":"2.12","trade":null,"ind":"2.06"},{"date":"2025.10.20","stock":"-0.40","trade":null,"ind":"0.98"},{"date":"2025.10.17","stock":"-0.53","trade":null,"ind":"-3.04"},{"date":"2025.10.16","stock":"-0.52","trade":null,"ind":"-0.25"},{"date":"2025.10.15","stock":"3.24","trade":null,"ind":"1.73"},{"date":"2025.10.14","stock":"-1.59","trade":null,"ind":"-2.54"},{"date":"2025.10.13","stock":"-0.26","trade":null,"ind":"-0.93"},{"date":"2025.10.10","stock":"1.21","trade":null,"ind":"-2.70"},{"date":"2025.10.09","stock":"-1.19","trade":null,"ind":"1.47"},{"date":"2025.09.30","stock":"0.67","trade":null,"ind":"0.35"},{"date":"2025.09.29","stock":"0.00","trade":null,"ind":"2.05"},{"date":"2025.09.26","stock":"-1.57","trade":null,"ind":"-1.76"},{"date":"2025.09.25","stock":"-0.39","trade":null,"ind":"0.67"},{"date":"2025.09.24","stock":"1.46","trade":null,"ind":"1.80"},{"date":"2025.09.23","stock":"-2.58","trade":null,"ind":"-0.29"},{"date":"2025.09.22","stock":"0.52","trade":null,"ind":"0.67"},{"date":"2025.09.19","stock":"-1.79","trade":null,"ind":"-0.04"},{"date":"2025.09.18","stock":"-1.75","trade":null,"ind":"-1.06"},{"date":"2025.09.17","stock":"-2.44","trade":null,"ind":"1.16"}]
利德曼,深证成指,医疗器械指数
压力支撑
该股压力位为7.95元，支撑位为7.68元。
[{"text":"\u538b\u529b\u4f4d","value":"7.95","date":1761148800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.68","date":1761148800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.9资金面打败了57%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月24日 08:10
| 机构今日流向(万元) | -460.25 | 机构5日流向(万元) | -2454.60 |
| 机构10日流向(万元) | -5540.82 | 机构20日流向(万元) | -10818.16 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加220.03万股，其中基金净增仓3家，主力净增仓44家，有一定的中长期投资价值。
截止2025-06-30，共74家主力机构（基金71家，一般法人3家），持仓量总计26999.47万股，占流通A股49.71%
其中，基金持仓与2024-12-31相比：
增仓：11家 ，增持 186.81万股
减仓：8家 ，减持 3.27万股
新出现在主力名单中：52家 ，持有978.63万股
从主力名单中消失：8家 ，原持有26.1万股
其中，基金持仓与2024-12-31相比：
增仓：11家 ，增持 186.81万股
减仓：8家 ，减持 3.27万股
新出现在主力名单中：52家 ，持有978.63万股
从主力名单中消失：8家 ，原持有26.1万股
消息面诊股
诊断结果：5.7消息面打败了29%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 利德曼（截止2025年10月20日）股东人数为33
2025-10-22 - 利德曼（截止2025年9月30日）股东人数为329
2025-10-10 - 利德曼：郑允新先生任职公司董事期间，未持有公司股份
2025-09-25 - 利德曼：非独立董事郑允新辞职
2025-09-24 - 利德曼（截止2025年9月19日）股东人数为335
2025-09-23 - 北京医学会第十九届检验医学学术会议&京沪论坛圆满落
2025-09-16 - 利德曼获16家机构调研：公司本次资产重组交易资金来
2025-09-16 - 基金调研丨浦银安盛基金调研利德曼
2025-09-15 - 利德曼（截止2025年9月10日）股东人数为353
2025-09-12 - 利德曼：目前资产重组项目正常推进中
2025-09-09
消息列表
| 一般消息 | 高管变动 | 因工作变动原因 | 2025-09-24 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-07-30 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-03-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-03-28 |
| 一般消息 | 募资投向 | 2025-03-27 | |
| 利空 | 业绩预告 | 业绩预亏 | 2025-01-22 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：3.5行业面打败了45%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2025.10.23","price":"0.22","value":null},{"date":"2025.10.22","price":"-0.62","value":null},{"date":"2025.10.21","price":"2.06","value":null},{"date":"2025.10.20","price":"0.98","value":null},{"date":"2025.10.17","price":"-3.04","value":null},{"date":"2025.10.16","price":"-0.25","value":null},{"date":"2025.10.15","price":"1.73","value":null},{"date":"2025.10.14","price":"-2.54","value":null},{"date":"2025.10.13","price":"-0.93","value":null},{"date":"2025.10.10","price":"-2.70","value":null},{"date":"2025.10.09","price":"1.47","value":null},{"date":"2025.09.30","price":"0.35","value":null},{"date":"2025.09.29","price":"2.05","value":null},{"date":"2025.09.26","price":"-1.76","value":null},{"date":"2025.09.25","price":"0.67","value":null},{"date":"2025.09.24","price":"1.80","value":null},{"date":"2025.09.23","price":"-0.29","value":null},{"date":"2025.09.22","price":"0.67","value":null},{"date":"2025.09.19","price":"-0.04","value":null},{"date":"2025.09.18","price":"-1.06","value":null},{"date":"2025.09.17","price":"1.16","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 振德医疗 | 87.80% | 9.43% | 6.4分 |
| 2 | - | 12.61% | 18.15% | 分 |
| 3 | 春立医疗 | 12.57% | 6.41% | 6.6分 |
| 4 | 英科医疗 | 10.68% | -11.65% | 5.7分 |
| 5 | 祥生医疗 | 10.07% | 0.30% | 5.7分 |
| 6 | 惠泰医疗 | 8.74% | 6.47% | 6.5分 |
| 8 | 圣湘生物 | 7.98% | 6.36% | 6.2分 |
| 10 | 楚天科技 | 6.67% | -6.58% | 4.7分 |
| 12 | ST凯利 | 4.78% | 0.68% | 5.5分 |
| 14 | - | 3.49% | -2.55% | 分 |
| 16 | 东富龙 | 2.92% | 0.00% | 5.7分 |
| 18 | 九安医疗 | 2.70% | -0.93% | 5.7分 |
| 20 | 明德生物 | 1.45% | 1.03% | 5.1分 |
| 22 | 奕瑞科技 | 0.85% | -1.23% | 6.0分 |
| 24 | 达安基因 | 0.78% | 1.89% | 5.7分 |
| 26 | 国发股份 | 0.68% | 5.34% | 6.1分 |
| 28 | 艾德生物 | 0.39% | 3.76% | 6.1分 |
| 30 | 爱威科技 | 0.30% | 3.39% | 6.5分 |
| 32 | 利德曼 | -0.13% | 4.73% | 5.7分 |
| 34 | 科华生物 | -0.30% | 4.21% | 5.5分 |
| 36 | 麦克奥迪 | -0.62% | 0.06% | 5.5分 |
| 38 | 华强科技 | -1.02% | -2.59% | 5.3分 |
| 40 | 透景生命 | -1.18% | -10.08% | 4.8分 |
| 42 | 仁度生物 | -1.39% | -1.14% | 5.2分 |
| 44 | 海利生物 | -1.40% | 0.43% | 5.9分 |
| 46 | 赛诺医疗 | -1.54% | -3.00% | 5.6分 |
| 48 | 普门科技 | -1.84% | -2.12% | 5.4分 |
| 50 | 华大智造 | -1.88% | 0.37% | 4.9分 |
| 52 | 赛科希德 | -1.97% | 2.48% | 5.7分 |
| 54 | 迪瑞医疗 | -2.08% | 0.52% | 4.9分 |
| 56 | 基蛋生物 | -2.26% | 1.11% | 6.2分 |
| 58 | 美康生物 | -2.41% | 1.94% | 5.2分 |
| 60 | 西山科技 | -2.79% | -0.96% | 5.4分 |
| 62 | 澳华内镜 | -2.88% | 2.79% | 5.1分 |
| 64 | 阳普医疗 | -3.06% | 4.21% | 6.0分 |
| 66 | 力诺药包 | -3.16% | 5.30% | 5.5分 |
| 68 | 三友医疗 | -3.27% | -1.64% | 4.9分 |
| 70 | 五洲医疗 | -3.45% | -0.11% | 4.8分 |
| 72 | 山外山 | -3.52% | -3.20% | 5.6分 |
| 74 | 微电生理 | -3.72% | 6.56% | 6.4分 |
| 76 | 健尔康 | -3.87% | 1.13% | 5.6分 |
| 78 | 鱼跃医疗 | -3.98% | -2.94% | 5.5分 |
| 80 | 新华医疗 | -4.25% | -2.32% | 5.7分 |
| 82 | 正海生物 | -4.49% | -0.55% | 5.2分 |
| 84 | 爱迪特 | -4.64% | -0.79% | 5.9分 |
| 86 | 尚荣医疗 | -4.82% | 3.75% | 5.3分 |
| 88 | 大博医疗 | -5.01% | -5.22% | 5.9分 |
| 90 | 戴维医疗 | -5.15% | -0.86% | 5.8分 |
| 92 | 康拓医疗 | -5.25% | 1.39% | 5.9分 |
| 94 | 康众医疗 | -5.40% | -0.29% | 5.3分 |
| 96 | 南微医学 | -5.84% | -4.41% | 5.8分 |
| 98 | 三诺生物 | -5.93% | -0.46% | 5.3分 |
| 100 | 开立医疗 | -6.06% | -3.07% | 4.8分 |
| 102 | 冠昊生物 | -6.48% | -0.64% | 6.1分 |
| 104 | 中源协和 | -6.55% | -5.65% | 4.7分 |
| 106 | 万泰生物 | -7.32% | -1.52% | 4.7分 |
| 108 | 安必平 | -7.41% | -0.85% | 5.0分 |
| 110 | 乐心医疗 | -7.62% | -0.65% | 5.9分 |
| 112 | 爱朋医疗 | -7.72% | -4.13% | 4.4分 |
| 114 | 迈普医学 | -7.80% | -1.44% | 5.2分 |
| 116 | 万东医疗 | -8.56% | -3.04% | 5.4分 |
| 118 | - | -9.43% | 2.86% | 分 |
| 120 | 之江生物 | -9.92% | 0.98% | 4.6分 |
| 122 | 伟思医疗 | -10.14% | -4.75% | 5.4分 |
| 124 | 新产业 | -11.28% | -0.71% | 5.2分 |
| 126 | 天臣医疗 | -12.64% | 3.85% | 5.5分 |
| 128 | 翔宇医疗 | -14.54% | -3.26% | 5.5分 |
| 130 | 威高骨科 | -18.97% | -1.56% | 5.7分 |
| 132 | 济民健康 | -25.72% | -12.16% | 4.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 104/247 ， 71/247。
[{"date":"2025-06-30","value":"-0.26","vol":"2.27"},{"date":"2025-03-31","value":"-0.08","vol":"1.15"},{"date":"2024-12-31","value":"-4.41","vol":"0.53"},{"date":"2024-09-30","value":"0.06","vol":"4.75"},{"date":"2024-06-30","value":"0.03","vol":"3.53"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-0.26 | -0.08 | -4.41 | 0.06 | 0.03 |
| 行业(%) | 2.27 | 1.15 | 0.53 | 4.75 | 3.53 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"52.02","vol":"52.10"},{"date":"2025-03-31","value":"53.56","vol":"51.81"},{"date":"2024-12-31","value":"52.11","vol":"52.63"},{"date":"2024-09-30","value":"54.16","vol":"53.58"},{"date":"2024-06-30","value":"55.72","vol":"53.70"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
52.02 | 53.56 | 52.11 | 54.16 | 55.72 |
| 行业(%) | 52.10 | 51.81 | 52.63 | 53.58 | 53.70 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 97/247 ， 125/247。
[{"date":"2025-06-30","value":"-14.80","vol":"-1.71"},{"date":"2025-03-31","value":"-16.61","vol":"-0.92"},{"date":"2024-12-31","value":"-19.79","vol":"0.64"},{"date":"2024-09-30","value":"-17.15","vol":"0.79"},{"date":"2024-06-30","value":"-17.01","vol":"0.16"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-14.80 | -16.61 | -19.79 | -17.15 | -17.01 |
| 行业(%) | -1.71 | -0.92 | 0.64 | 0.79 | 0.16 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-800.43","vol":"-20.27"},{"date":"2025-03-31","value":"53.73","vol":"-4.25"},{"date":"2024-12-31","value":"-589.66","vol":"-24.11"},{"date":"2024-09-30","value":"-95.49","vol":"-20.40"},{"date":"2024-06-30","value":"-96.32","vol":"8.56"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-800.43 | 53.73 | -589.66 | -95.49 | -96.32 |
| 行业(%) | -20.27 | -4.25 | -24.11 | -20.40 | 8.56 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 101/247 ， 73/247。
[{"date":"2025-06-30","value":"0.09","vol":"0.17"},{"date":"2025-03-31","value":"0.04","vol":"0.08"},{"date":"2024-12-31","value":"0.20","vol":"0.35"},{"date":"2024-09-30","value":"0.15","vol":"0.26"},{"date":"2024-06-30","value":"0.10","vol":"0.18"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.09 | 0.04 | 0.20 | 0.15 | 0.10 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.26 | 0.18 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.85","vol":"1.13"},{"date":"2025-03-31","value":"0.41","vol":"0.55"},{"date":"2024-12-31","value":"2.00","vol":"2.33"},{"date":"2024-09-30","value":"1.40","vol":"1.67"},{"date":"2024-06-30","value":"0.93","vol":"1.13"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.85 | 0.41 | 2.00 | 1.40 | 0.93 |
| 行业(次) | 1.13 | 0.55 | 2.33 | 1.67 | 1.13 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 113/247 ， 7/247。
[{"date":"2025-06-30","value":"-12.03","vol":"15.06"},{"date":"2025-03-31","value":"13.55","vol":"4.01"},{"date":"2024-12-31","value":"17.78","vol":"29.58"},{"date":"2024-09-30","value":"24.13","vol":"15.37"},{"date":"2024-06-30","value":"16.67","vol":"13.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -12.03 | 13.55 | 17.78 | 24.13 | 16.67 |
| 行业 | 15.06 | 4.01 | 29.58 | 15.37 | 13.04 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.17","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.44","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"0.47","vol":"2.31"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.17 | - | 0.44 | - | 0.47 |
| 行业 | 1.57 | 0.00 | 2.19 | 0.01 | 2.31 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 126/247 ， 125/247。
[{"date":"2025-06-30","value":"15.53","vol":"5.50"},{"date":"2025-03-31","value":"15.64","vol":"5.89"},{"date":"2024-12-31","value":"13.63","vol":"5.34"},{"date":"2024-09-30","value":"14.83","vol":"5.97"},{"date":"2024-06-30","value":"14.16","vol":"5.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
15.53 | 15.64 | 13.63 | 14.83 | 14.16 |
| 行业 | 5.50 | 5.89 | 5.34 | 5.97 | 5.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"13.99","vol":"4.40"},{"date":"2025-03-31","value":"14.15","vol":"4.77"},{"date":"2024-12-31","value":"12.37","vol":"4.32"},{"date":"2024-09-30","value":"11.98","vol":"4.82"},{"date":"2024-06-30","value":"12.83","vol":"4.90"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
13.99 | 14.15 | 12.37 | 11.98 | 12.83 |
| 行业 | 4.40 | 4.77 | 4.32 | 4.82 | 4.90 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 125/247 ， 122/247。
[{"date":"2025-06-30","value":"5.23","vol":"22.01"},{"date":"2025-03-31","value":"5.13","vol":"21.24"},{"date":"2024-12-31","value":"5.70","vol":"21.92"},{"date":"2024-09-30","value":"5.11","vol":"21.09"},{"date":"2024-06-30","value":"5.28","vol":"21.07"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
5.23 | 5.13 | 5.70 | 5.11 | 5.28 |
| 行业(%) | 22.01 | 21.24 | 21.92 | 21.09 | 21.07 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.06","vol":"0.58"},{"date":"2025-03-31","value":"0.06","vol":"0.57"},{"date":"2024-12-31","value":"0.06","vol":"0.55"},{"date":"2024-09-30","value":"0.06","vol":"0.38"},{"date":"2024-06-30","value":"0.06","vol":"0.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| 行业(%) | 0.58 | 0.57 | 0.55 | 0.38 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.22","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-0.56","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.15","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.75","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]